Waverly Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.03M | Buy |
83,970
+3,050
| +4% | +$235K | 0.05% | 363 |
|
|
2025
Q4 | $6.42M | Buy |
80,920
+55,159
| +214% | +$4.35M | 0.05% | 323 |
|
|
2025
Q3 | $1.94M | Buy |
25,761
+3,498
| +16% | +$240K | 0.02% | 518 |
|
|
2025
Q2 | $1.54M | Sell |
22,263
-5,544
| -20% | -$364K | 0.02% | 539 |
|
|
2025
Q1 | $1.88M | Buy |
27,807
+8,736
| +46% | +$523K | 0.02% | 489 |
|
|
2024
Q4 | $856K | Buy |
19,071
+1,392
| +8% | +$78.1K | 0.01% | 555 |
|
|
2024
Q3 | $1.11M | Buy |
17,679
+772
| +5% | +$45K | 0.02% | 430 |
|
|
2024
Q2 | $999K | Buy |
16,907
+2,850
| +20% | +$178K | 0.02% | 434 |
|
|
2024
Q1 | $1.12M | Buy |
14,057
+2,815
| +25% | +$215K | 0.03% | 348 |
|
|
2023
Q4 | $888K | Buy |
11,242
+6,995
| +165% | +$498K | 0.03% | 234 |
|
|
2023
Q3 | $297K | Buy |
4,247
+71
| +2% | +$5.03K | 0.01% | 326 |
|
|
2023
Q2 | $289K | Buy |
4,176
+325
| +8% | +$23.1K | 0.01% | 305 |
|
|
2023
Q1 | $286K | Sell |
3,851
-91
| -2% | -$7.63K | 0.01% | 240 |
|
|
2022
Q4 | $367K | Sell |
3,942
-56
| -1% | -$5.4K | 0.02% | 204 |
|
|
2022
Q3 | $381K | Buy |
3,998
+137
| +4% | +$13.6K | 0.03% | 178 |
|
|
2022
Q2 | $357K | Buy |
3,861
+264
| +7% | +$25.8K | 0.03% | 152 |
|
|
2022
Q1 | $364K | Sell |
3,597
-53
| -1% | -$5.57K | 0.03% | 145 |
|
|
2021
Q4 | $380K | Buy |
3,650
+284
| +8% | +$26.2K | 0.03% | 143 |
|
|
2021
Q3 | $317K | Buy |
3,366
+629
| +23% | +$52.7K | 0.03% | 166 |
|
|
2021
Q2 | $231K | Sell |
2,737
-66
| -2% | -$5.41K | 0.02% | 174 |
|
|
2021
Q1 | $250K | Buy |
+2,803
| New | +$204K | 0.02% | 154 |
|
|
2018
Q1 | – | Sell |
-19,371
| Closed | -$1.41M | – | 228 |
|
|
2017
Q4 | $1.41M | Buy |
19,371
+491
| +3% | +$35.7K | 0.2% | 72 |
|
|
2017
Q3 | $1.53M | Buy |
18,880
+2,120
| +13% | +$168K | 0.33% | 53 |
|
|
2017
Q2 | $1.35M | Buy |
16,760
+321
| +2% | +$25.3K | 0.34% | 56 |
|
|
2017
Q1 | $1.29M | Buy |
+16,439
| New | +$1.31M | 0.34% | 55 |
|
|
2015
Q4 | – | Sell |
-325
| Closed | -$31K | – | 187 |
|
|
2015
Q3 | $31K | Buy |
+325
| New | +$34.2K | 0.02% | 194 |
|
|
2015
Q1 | – | Sell |
-132
| Closed | -$13K | – | 350 |
|
|
2014
Q4 | $13K | Sell |
132
-161
| -55% | -$14.2K | 0.01% | 263 |
|
|
2014
Q3 | $23K | Buy |
293
+57
| +24% | +$4.49K | 0.01% | 318 |
|
|
2014
Q2 | $18K | Sell |
236
-37
| -14% | -$2.8K | 0.01% | 346 |
|
|
2014
Q1 | $20K | Sell |
273
-5,043
| -95% | -$356K | 0.01% | 318 |
|
|
2013
Q4 | $380K | Sell |
5,316
-83
| -2% | -$5.33K | 0.13% | 92 |
|
|
2013
Q3 | $306K | Buy |
5,399
+143
| +3% | +$8.52K | 0.16% | 67 |
|
|
2013
Q2 | $301K | Buy |
+5,256
| New | +$305K | 0.17% | 69 |
|
Other funds holding CVS
VCM
VPM
Waverly Advisors's CVS Position: Q1 2026 in Review
Waverly Advisors increased its CVS Health (CVS) stake by 3.8% in Q1 2026, buying an estimated $235K and bringing the position to 83,970 shares worth $6.03M. The position accounts for 0.05% of the portfolio, ranked #363.
Waverly Advisors first reported a position in CVS in Q2 2013 and has held it in 33 quarters since. The position peaked at $6.42M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Waverly Advisors held 83,970 shares of CVS Health worth $6.03M as of Q1 2026.
- Waverly Advisors bought 3,050 CVS Health shares in Q1 2026, an estimated $235K.
- CVS Health made up 0.05% of Waverly Advisors's portfolio in Q1 2026, its #363 holding.
- Waverly Advisors first reported a position in CVS Health in Q2 2013 and has held it in 33 quarters since.
- Waverly Advisors's CVS Health position peaked at $6.42M in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.